Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06001333Not ApplicableRecruiting

Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract

NCT03343119Unknown

Epidemiology of Resistant Microbial Strains Among Different Groups of People (Healthy, Infected and Exposed to Animals)

NCT02623413UnknownPrimary

Cohort Study of German Hematological / Oncological Wards to Assess the Effect of Contact Precautions on Nosocomial Colonization With Vancomycin Resistant Enterococci

Showing all 3 trials

Research Network

Activity Timeline